Scopolamine Market Scope
Scopolamine is an alkaloid drug extracted from a plant called henbane used to treat nausea and motion sickness and to further dilate the pupil during ophthalmic procedures. Scopolamine belongs to a class of drugs called anticholinergics. It blocks the activity of the neurotransmitter acetylcholine, which stimulates the part of the brain that causes nausea and vomiting, involuntary muscle movements in the lungs, gastrointestinal and urinary tracts. Scopolamine reduces the secretion of certain organs in the body, such as the stomach and intestines. Scopolamine also decreases nerve signals that make your stomach vomit. Scopolamine is used to prevent nausea and vomiting from motion sickness or anesthesia during surgery. Scopolamine is also used to treat certain stomach or intestinal problems, muscle cramps, and Parkinson's-like conditions. An overdose of scopolamine can be fatal. Overdose symptoms may include fever, warmth, vomiting, restlessness or excitement, confusion, hallucinations, weak or shallow breathing, or fits (convulsions). This medicine can cause blurred vision, thinking, and reactions. Scopolamine can reduce sweating, making it more prone to heatstroke. Scopolamine can also dilate the pupils and make the eyes more sensitive to light.
The market study is being classified by Type (Scopolamine Butylbromide, Scopolamine Hydrobromide and Scopolamine Base), by Application (Oral, Injection and Patches) and major geographies with country level break-up.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Asia Pacific Players will contribute to the maximum growth of Global Scopolamine market throughout the predicted period.
Baxter International Inc. (United States), GlaxoSmithKline plc. Novartis AG (United Kingdom), Perrigo Company plc. (Dublin), Caleb Pharmaceuticals, Inc. (Taiwan), Myungmoon Pharma Co. Ltd. (South Korea), Alchem International (India), Phytex Australia (Australia), Centroflora Group (Brazil), Alkaloids of Australia (Australia) and Fine Chemicals Corporation (South Africa) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Vista Medical Ltd. (Canada) and Ohmatex ApS (Denmark).
AdvanceMarketAnalytics has segmented the market of Global Scopolamine market by Type, Application and Region.
On the basis of geography, the market of Scopolamine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: antihistamines such as meclizine (Antivert, Bonine, others); medications for anxiety, irritable bowel disease, motion sickness, pain, Parkinson's disease, seizures or urinary problems; muscle relaxants; sedatives; sleeping pills; tranquilizers; or tricyclic antidepressants such as desipramine (Norpramin), clomipramine (Anafranil), imipramine (Tofranil), and trimipramine (Surmontil) Many other medications may also interact with scopolamine patch, so be sure to tell the doctor about all the medications that are being taken, even those that do not appear.
- Growth in the Number of Travelers around the Globe
- The Growing Medical Tourism for Surgeries
- Increasing Prevalence of Motion Sickness
- Increasing Number of Population Suffering From Stress and Anxiety Disorder
- Increased Expenditure on Healthcare
- Increasing Consumption of Unhealthy Food Leading To Obesity and Other Stomach Related Infections
- Diagnostic or Staging Test in the Evaluation of the Cholinergic System
- Stringent Regulations against the Manufacturing and Marketing of the Drug
- Abuse Of Drugs in Various Regions Illegally
Key Target AudienceManufacturers of Scopolamine, Suppliers and Distributors of Scopolamine, End-Users, Potential Investors, Market Research Firms and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase